Infineon Technologies IPAW Series

2 variants · Infineon TechnologiesAll Discrete Semiconductors →

About the Infineon Technologies IPAW Series

The Infineon Technologies IPAW Series series groups 2 related part numbers, each listed with full specifications, a datasheet where available, and an RFQ option. Every variant in the range shares a common case of TO-220-3 Full Pack, drain to source voltage of 700 V and drive voltage (Max rds on, min rds on) of 10V. Variants differ by current - continuous drain (Id) @ 25°C, gate charge (Qg) (Max) @ vgs and input capacitance (Ciss) (Max) @ vds, so you can match the exact current - continuous drain (Id) @ 25°C your application requires using the selection guide below. Listed Infineon Technologies IPAW Series part numbers are obsolete or end-of-life — we specialise in sourcing discontinued and hard-to-find Infineon Technologies IPAW Series components.

Select a variant by

Current - continuous drain (Id) @ 25°C: 7.4A (Tc) · 10.5A (Tc)
Gate charge (Qg) (Max) @ vgs: 15.3 nC @ 10 V · 22 nC @ 10 V
Input capacitance (Ciss) (Max) @ vds: 328 pF @ 100 V · 474 pF @ 100 V
Power dissipation: 68W (Tc) · 86W (Tc)
Rds on (Max) @ id, vgs: 600mOhm @ 1A, 10V · 950mOhm @ 1.5A, 10V
Vgs(th) (Max) @ id: 3.5V @ 150µA · 3.5V @ 210µA

Shared specifications

Case: TO-220-3 Full Pack
Drain to source voltage: 700 V
Drive voltage (Max rds on, min rds on): 10V
FET feature: -
FET type: N-Channel
Mounting: Through Hole
Operating temperature: -40°C ~ 150°C (TJ)
Package: Tube
Technology: MOSFET (Metal Oxide)
Vgs: ±20V

Variant comparison

Parameter	IPAW70R600CEXKSA1	IPAW70R950CEXKSA1
Current - continuous drain (Id) @ 25°C	10.5A (Tc)	7.4A (Tc)
Gate charge (Qg) (Max) @ vgs	22 nC @ 10 V	15.3 nC @ 10 V
Input capacitance (Ciss) (Max) @ vds	474 pF @ 100 V	328 pF @ 100 V
Power dissipation	86W (Tc)	68W (Tc)
Rds on (Max) @ id, vgs	600mOhm @ 1A, 10V	950mOhm @ 1.5A, 10V
Vgs(th) (Max) @ id	3.5V @ 210µA	3.5V @ 150µA

Request a quote on any Infineon Technologies IPAW Series part number and we confirm price, availability and lead time per line — including end-of-life and allocation-constrained variants.